Recently it has been reported, that increased serum angiogenin correlated with dynamic contrast-enhanced MR-PET parameters in NSCLC patients, which were improved under anti-angiogenic therapy and linked with OS (36). This evidence concerns the gene ANG and non-small cell lung carcinoma.